Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics

DSpace Repository

Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics

Author: Jayne, David R. W.; Terrier, Benjamin; Hellmich, Bernhard; Khoury, Farieez; Baylis, Lee; Bentley, Jane H.; Steinfeld, Jonathan; Yancey, Steven W.; Kwon, Namhee; Wechsler, Michael E.; Akuthota, Praveen
Tübinger Autor(en):
Hellmich, Bernhard
Published in: Erj Open Research (2024), Bd. 10, H. 1
Verlagsangabe: Sheffield : European Respiratory Soc Journals Ltd
Language: English
Full text: http://dx.doi.org/10.1183/23120541.00509-2023
ISSN: 2312-0541
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)